SEC Tracker
Get the app

Prime Medicine PRME

Prime Medicine reports $61.2M cash as of Sept 30, 2026

Prime Medicine (PRME) filed an 8-K with the SEC on Nov 10, 2026, 4:08 pm ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results, Item 8.01 Other events

Form
8-K
Filed
Importance
Major
  1. Preliminary cash, cash equivalents, and short-term investments: $61.2M as of Sept 30, 2026
  2. Restricted cash: $13.7M as of Sept 30, 2026
  3. Financial results not yet finalized and subject to change

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Prime Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.